Dr. AHMET TAYYAR

Gynecology and Obstetrics , Perinatology and High-Risk Pregnancies

Education

• 2018Istanbul Medipol University Faculty of Medicine / Department of Obstetrics and Gynecology / Associate Professor
• 2016King`s College Hospital NHS Foundation Trust, Department of Obstetrics, Harris Birthright Research Center For Fetal Medicine – Fetal Medicine Research Institute, Londra, İngiltere / Perinatoloji Yan Dal Uzmanı
• 2011Erciyes University Faculty of Medicine Department of Obstetrics and Gynaecology
• 2005Ankara University Faculty of Medicine

Experience

• 2020Acıbadem Health Group
• 2018 – 2020Medipol Mega University Hospital / Department of Obstetrics and Gynecology / Perinatology Clinic
• 2016 – 2018Istanbul Health Sciences University Kanuni Sultan Suleyman Training and Research Hospital / Perinatology Clinic
• 2013 – 2016King`s College Hospital NHS Foundation Trust, Department of Obstetrics, Harris Birthright Research Center For Fetal Medicine – Fetal Medicine Research Institute, Londra, İngiltere
• 2011 – 2013Nigde State Hospital / Gynecology and Obstetrics Clinic

Memberships

• Turkish Maternal-Fetal Medicine and Perinatology Association

PUBLICATIONS

• Maternal serum galectin-1 and galectin-3 levels in pregnancies complicated with preterm prelabor rupture of membranesThe Journal of Maternal-Fetal & Neonatal Medicine, 2020, 33:5, 861-868, DOI: 10.1080/14767058.2019.1637409 Kaya B, Turhan U, Sezer S, Kaya S, Dag I, Tayyar A.
• Type 4 laryngotracheoesophageal cleft detected during fetoscopic endoluminal tracheal occlusion in a fetus with severe congenital diaphragmatic herniaUltrasound Obstet Gynecol. 2020, doi:10.1002/uog.20355 Yuksel, MA and Tayyar A,
• The assessment of cardiac function with tissue Doppler imaging in fetuses with congenital diaphragmatic herniaThe Journal of Maternal-Fetal & Neonatal Medicine, 2020, 33:7, 1233-1238, DOI: 10.1080/14767058.2019.1674806 Kaya B, Tayyar A, Sezer S, Kaya S.
• Maternal serum mitofusin-2 levels in patients with preeclampsia: the possible role of mitochondrial dysfunction in preeclampsiaThe Journal of Maternal-Fetal & Neonatal Medicine, 2019 ,DOI: 10.1080/14767058.2018.1532497 Aydogan BM, Yuksel I, Tayyar A, Aslan Cetin B, Tayyar AT, Koroglu N.
• Wnt signaling pathway in early-and late-onset preeclampsia: evaluation with Dickkopf-1 and R-Spondin-3 glycoproteinsArchives of gynecology and obstetrics. 2019 Jun 1;299(6):1551-6. Tayyar AT, Karakus R, Sahin ME, Topbas NF, Sahin E, Karakus S, Yalcın ET, Tayyar A.
• Comparison of fetal cardiac functions between small-for-gestational age fetuses and late-onset growth-restricted fetusesJournal of Perinatal Medicine, 2019, DOI: https://doi.org/10.1515/jpm-2019-0206 Kaya B, Tayyar A, Kanber Acar D, Kaya S.
• Assessment of fetal right ventricular myocardial performance index changes following intrauterine transfusionThe Journal of Maternal-Fetal & Neonatal Medicine. 2019 Oct 12:1-4. Temel Yüksel İ, Acar D, Turhan U, Aslan Çetİn B, Köroğlu N, Şenol G, Tayyar A, Yüksel MA.
• Perinatal outcomes of intrauterine transfusion for foetal anaemia due to red blood cell alloimmunisationJournal of Obstetrics and Gynecology. 2019 Aug 26:1-5. Shavkli AO, Cetin BA, Acar Z, Ozkose Z, Behram M, Chaypinar SS, Tayyar A, Yuksel MA.
• Maternal serum sestrin 2 levels in preeclampsia and their relationship with the severity of the diseaseHypertens Pregnancy, 2018, 1-7. doi:10.1080/10641955.2018.1540702 Tayyar, AT, Tayyar, A., Kozali, S., Karakus, R., Eser, A., Abide Yayla, C., Yalcın ET, Dag I, Eroglu, M.
• Increased maternal C1q/TNF-related protein-1 (CTRP-1) serum levels in pregnancies with preeclampsiaThe Journal of Maternal-Fetal Neonatal Medicine, 2018, Doi :10.1080/14767058.2018.1498838 Acar DK, Tayyar A, Yuksel A, Atys A, Twin A, Topcu G.
• Maternal cytoglobin (CYGB) serum levels in normal and preeclamptic pregnancies.The Journal of Maternal-Fetal Neonatal Medicine, 2018, Doi: 10.1080/14767058.2017.1421927 Tayyar AT, Tayyar A, Kozalı S, Karakus R, Karakus S, Temel YI, Dag Ismail, Yetkin Yildirim Gonca, Demirci Oya
• Increased levels of the novel hepatokine fetuin B in patients with intrahepatic cholestasis of pregnancy.The Journal of Maternal-Fetal Neonatal Medicine 2017; 1-6., Doi: 10.1080/14767058.2017.1413546 Koroglu N, Tayyar A, Tola EN, Yetkin YG, Temel YI, Aslan Cetin B, Dag I, Acar DK.
• Could first- and second-trimester biochemical markers for Down Syndrome have a role in predicting intrahepatic cholestasis of pregnancy?Archives of Medical Science 2017; Doi: 10.5114/aoms.2017.69865 Tayyar AT, Tayyar A, Atakul T, Yayla CA, Kilicci C, Eser A, Karakus R, Herkiloglu D, Cundubey CR, Tayyar M.
• Evaluation of FGF-19 and Beta-Klotho as biomarkers in patients with intrahepatic cholestasis of pregnancyArchives of Medical Science 2017; Doi: 10.5114/aoms.2017.72424 Tayyar AT, Tayyar A, Kozali S, Karakus R, Koroglu N, Temel Yuksel I, Yetkin Yildirim G, Dag I, Eroglu M
• Upper limb hemimelia in a twin pregnancy which was obtained by an ICSI and PGD in a woman with mosaic Turners Syndrome and the prognosis.Organogenesis 2017;13(4), 179-182., Doi: 10.1080/15476278.2017.1358842 Tayyar AT, Tayyar A, Eser A, Kilicci C,Yenidede I, Selcuk S.
• Maternal copeptin levels in intrahepatic cholestasis of pregnancyJ Matern Fetal Neonatal Med. 2017 Jun; 14:1-5. doi: 10.1080/14767058.2017.1335708. Tayyar A, Temel Yuksel I, Koroglu N, Tayyar AT, Davutoglu Alici E, Akkaya Firat A, Aslan Cetin B.
• Mean arterial pressure at 12, 22, 32 and 36 weeks gestation in screening for preeclampsiaUltrasound Obstet Gynecol. 2016 May;47(5):573-9. Tayyar A, Krinitakis K, Wright A, Wright D, Nicolaides KH.
• Uterine artery pulsatility index in the three trimesters of pregnancy: effects of maternal characteristics and medical history.Ultrasound Obstet Gynecol. 2015 Jun;45(6):689-97. Tayyar A, Guerra L, Wright A, Wright D, Nicolaides KH.
• Competing risk model in screening for preeclampsia by mean arterial pressure and uterine artery pulsatility index at 30-33 weeks” gestationFetal Diagn Ther. 2014;36(1):18-27. Tayyar A, Garcia-Tizon Larroca S, Poon LC, Wright D, Nicolaides KH.
• Competing risks model in screening for preeclampsia by biophysical and biochemical markers at 30-33 weeks” gestation.Fetal Diagn Ther. 2014;36(1):9-17. Garcia-Tizon Larroca S, Tayyar A, Poon LC, Wright D, Nicolaides KH.